SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 16.18 |
| Enterprise Value ($M) | 48.88 |
| Book Value ($M) | -45.39 |
| Book Value / Share | -0.88 |
| Price / Book | -0.36 |
| NCAV ($M) | -48.38 |
| NCAV / Share | -0.94 |
| Price / NCAV | -0.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.91 |
| Return on Equity (ROE) | -20.12 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.48 |
| Current Ratio | 0.48 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.73 |
| Assets | 7.72 |
| Liabilities | 53.11 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Halpern John D | |||
| 13G/A | Singer Nicholas Jason | |||
| 13G/A | Iaf, Llc | |||
| 13G/A | Freebird Partners LP |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 78,287 | 213,760 | 36.62 | |
| 126,287 | 578,566 | 21.83 | |
| 100,543 | 227,917 | 44.11 | |
| 333,617 | 924,837 | 36.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ENVB – Enveric Biosciences, Inc. | EPIX – ESSA Pharma Inc. |
| EQ – Equillium, Inc. | ESLA – Estrella Immunopharma, Inc. |
| EVOK – Evoke Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io